IN BRIEF: RTW Biotech Opportunities extends buyback by USD15 million
20th Oct 2025 10:34
RTW Biotech Opportunities Ltd - Guernsey-based investor in life sciences sector - Adds USD15 million to share buyback programme, aiming to close the discount of its share price to net asset value. RTW Biotech has USD5.8 million to complete from its current USD30 million buyback and will top that up by USD15 million, which is equivalent to about 9.2 million shares. Funds for the buyback come from several recent realisations of portfolio holdings. The company's most recently report net asset value, as of June 30, was USD1.70. Read More